-
公开(公告)号:US08232406B2
公开(公告)日:2012-07-31
申请号:US12942395
申请日:2010-11-09
申请人: David J. Lauffer , Robert J. Davies , Dean Stamos , Alexander Aronov , David D. Deininger , Ronald Grey, Jr. , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Kira McGinty
发明人: David J. Lauffer , Robert J. Davies , Dean Stamos , Alexander Aronov , David D. Deininger , Ronald Grey, Jr. , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Kira McGinty
IPC分类号: A61K31/4439
CPC分类号: C07D417/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D451/02 , C07D451/06 , C07D453/02 , C07D471/04 , C07D471/08 , C07D495/04 , C07D498/08 , C07D513/04 , C12N9/99
摘要: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用于蛋白激酶抑制剂的化合物。 本发明还提供了制备本发明化合物的方法,包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US08481524B2
公开(公告)日:2013-07-09
申请号:US12751016
申请日:2010-03-31
申请人: David Lauffer , Pan Li , Nathan Waal , Kira Mcginty , Qing Tang , Steven Ronkin , Luc Farmer , Dean Shannon , Dylan Jacobs
发明人: David Lauffer , Pan Li , Nathan Waal , Kira Mcginty , Qing Tang , Steven Ronkin , Luc Farmer , Dean Shannon , Dylan Jacobs
IPC分类号: C07D417/14
CPC分类号: C07D401/14 , C07D409/14 , C07D417/14
摘要: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.
-
公开(公告)号:US20110136789A1
公开(公告)日:2011-06-09
申请号:US12751016
申请日:2010-03-31
申请人: David Lauffer , Pan Li , Nathan Waal , Kira Mcginty , Qing Tang , Steven Ronkin , Luc Farmer , Dean Shannon , Dylan Jacobs
发明人: David Lauffer , Pan Li , Nathan Waal , Kira Mcginty , Qing Tang , Steven Ronkin , Luc Farmer , Dean Shannon , Dylan Jacobs
IPC分类号: A61K31/55 , C07D401/04 , A61K31/4439 , C07D401/14 , A61K31/4545 , A61P9/00 , A61P37/08 , A61P19/00 , A61P1/16 , A61P31/12 , A61P7/00 , A61P3/10 , A61P35/00 , C12N9/99
CPC分类号: C07D401/14 , C07D409/14 , C07D417/14
摘要: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.
摘要翻译: 本发明涉及可用于抑制c-Met蛋白激酶的式I化合物。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用该组合物治疗增殖性疾病的方法。
-
公开(公告)号:US20110059936A1
公开(公告)日:2011-03-10
申请号:US12942395
申请日:2010-11-09
申请人: David J. Lauffer , Robert J. Davies , Dean Stamos , Alexander Aronov , David D. Deininger , Ronald Grey, JR. , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Kira McGinty
发明人: David J. Lauffer , Robert J. Davies , Dean Stamos , Alexander Aronov , David D. Deininger , Ronald Grey, JR. , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Kira McGinty
IPC分类号: A61K31/497 , A61K31/5377 , A61K31/496 , A61K31/444 , A61K31/4439 , A61K31/501 , A61K31/537 , A61P35/00 , A61P35/04
CPC分类号: C07D417/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D451/02 , C07D451/06 , C07D453/02 , C07D471/04 , C07D471/08 , C07D495/04 , C07D498/08 , C07D513/04 , C12N9/99
摘要: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用于蛋白激酶抑制剂的化合物。 本发明还提供了制备本发明化合物的方法,包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US20070254868A1
公开(公告)日:2007-11-01
申请号:US11726170
申请日:2007-03-21
申请人: David Lauffer , Robert Davies , Dean Stamos , Alexander Aronov , David Deininger , Ronald Grey , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Bethiel , Dylan Jacobs , Kira McGinty
发明人: David Lauffer , Robert Davies , Dean Stamos , Alexander Aronov , David Deininger , Ronald Grey , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Bethiel , Dylan Jacobs , Kira McGinty
IPC分类号: A61K31/4439 , A61K31/437 , A61K31/454 , A61K31/55 , C07D213/82 , C07D401/04 , C07D471/04 , C12N9/99 , C07D403/14 , C07D223/00 , A61P35/00 , A61K31/497 , A61K31/44
CPC分类号: C07D417/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D451/02 , C07D451/06 , C07D453/02 , C07D471/04 , C07D471/08 , C07D495/04 , C07D498/08 , C07D513/04 , C12N9/99
摘要: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用于蛋白激酶抑制剂的化合物。 本发明还提供了制备本发明化合物的方法,包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US08575208B2
公开(公告)日:2013-11-05
申请号:US12528952
申请日:2008-02-20
申请人: Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Robert B. Perni , John Maxwell , Kevin Cottrell , Summer Halas
发明人: Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Robert B. Perni , John Maxwell , Kevin Cottrell , Summer Halas
IPC分类号: A61K31/4025 , C07D207/08
CPC分类号: C07D487/10 , C07D498/10
摘要: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
摘要翻译: 本发明涉及抑制丝氨酸蛋白酶活性,特别是丙型肝炎病毒NS3-NS4A蛋白酶活性的化合物。 因此,它们通过干扰丙型肝炎病毒的生命周期起作用,也可用作抗病毒剂。 本发明还涉及包含这些化合物的组合物,用于离体使用或给予患有HCV感染的患者。 本发明还涉及通过施用包含本发明化合物的组合物来治疗患者HCV感染的方法。
-
公开(公告)号:US07872031B2
公开(公告)日:2011-01-18
申请号:US11726170
申请日:2007-03-21
申请人: David J. Lauffer , Robert J. Davies , Dean Stamos , Alexander Aronov , David D. Deininger , Ronald Grey, Jr. , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Kira McGinty
发明人: David J. Lauffer , Robert J. Davies , Dean Stamos , Alexander Aronov , David D. Deininger , Ronald Grey, Jr. , Jinwang Xu , Pan Li , Brian Ledford , Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Kira McGinty
IPC分类号: A61K31/4439
CPC分类号: C07D417/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D451/02 , C07D451/06 , C07D453/02 , C07D471/04 , C07D471/08 , C07D495/04 , C07D498/08 , C07D513/04 , C12N9/99
摘要: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用于蛋白激酶抑制剂的化合物。 本发明还提供了制备本发明化合物的方法,包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US20100272681A1
公开(公告)日:2010-10-28
申请号:US12528952
申请日:2008-02-20
申请人: Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Robert B. Perni , John Maxwell , Kevin Cottrell , Summer Halas
发明人: Luc Farmer , Randy Scott Bethiel , Dylan Jacobs , Robert B. Perni , John Maxwell , Kevin Cottrell , Summer Halas
IPC分类号: A61K38/21 , C07D487/10 , C07D498/10 , A61K31/40 , A61K31/422 , A61K31/42 , A61K31/427 , A61P31/12 , A61K38/00
CPC分类号: C07D487/10 , C07D498/10
摘要: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.
摘要翻译: 本发明涉及抑制丝氨酸蛋白酶活性,特别是丙型肝炎病毒NS3-NS4A蛋白酶活性的化合物。 因此,它们通过干扰丙型肝炎病毒的生命周期起作用,也可用作抗病毒剂。 本发明还涉及包含这些化合物的组合物,用于离体使用或给予患有HCV感染的患者。 本发明还涉及通过施用包含本发明化合物的组合物来治疗患者HCV感染的方法。
-
-
-
-
-
-
-